Assessing expression patterns of PTGR1, a potential biomarker for acylfulven sensitivity in urothelial carcinoma., PMID:39523403
Association of ERCC1 rs11615 Polymorphism with the Risk of Cervical Cancer Especially in Chinese Populations: A Meta-Analysis., PMID:36245993
Does Molecular Profiling of KRAS-Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?, PMID:35877239
Dandelion Seed Extract Affects Tumor Progression and Enhances the Sensitivity of Cisplatin in Esophageal Squamous Cell Carcinoma., PMID:35668940
Evidence for Diverse Prognosis in High-Grade Serous Ovarian Carcinoma: Solid, Pseudoendometrioid, and Transitional-Like; So-Called "SET Morphology" and Progesterone Receptor Status., PMID:35147976
A newly established monoclonal antibody against ERCC1 detects major isoforms of ERCC1 in gastric cancer., PMID:34532603
Quantitative Multiplexed Proteomics Could Assist Therapeutic Decision Making in Non-Small Cell Lung Cancer Patients with Ambiguous ALK Test Results., PMID:34066104
ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependent., PMID:33952496
Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer., PMID:32944296
Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancer., PMID:32847480
Clinicopathological correlation of the expression of excision repair cross complementation group 1 (ERCC1) in oral cavity squamous cell carcinomas: an immunohistochemical study., PMID:32602295
ERCC1 expression in advanced colorectal cancer and matched liver metastases., PMID:32008866
Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA., PMID:30628188
Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling., PMID:30279363
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer., PMID:30224341
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine., PMID:29992976
ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer., PMID:29905882
A novel antibody-based approach to detect the functional ERCC1-202 isoform., PMID:29482102
Oxidation Products of 5-Methylcytosine are Decreased in Senescent Cells and Tissues of Progeroid Mice., PMID:29415265
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas., PMID:29187510
An expandable embryonic stem cell-derived Purkinje neuron progenitor population that exhibits in vivo maturation in the adult mouse cerebellum., PMID:28821816
ASCO 2016 - update colorectal liver metastases., PMID:28725278
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET)., PMID:27893326
Supplementation with Lactobacillus plantarum WCFS1 Prevents Decline of Mucus Barrier in Colon of Accelerated Aging Ercc1-/Δ7 Mice., PMID:27774093
Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors., PMID:27610644
The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells., PMID:27473273
Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model., PMID:27467592
Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment., PMID:27223437
Microglia replenished OHSC: A culture system to study in vivo like adult microglia., PMID:27145902
Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies., PMID:27002940
Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy., PMID:26868521
RRM1, ERCC1 and TS1 Immunofluorescence Expression in Leiomyosarcoma: A Tissue Microarray Study with Clinical Outcome Correlation Analysis., PMID:26612755
Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study., PMID:26372896
The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis., PMID:26179868
Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies., PMID:25619980
Treatment effect of buparlisib, cetuximab and irradiation in wild-type or PI3KCA-mutated head and neck cancer cell lines., PMID:25603975
ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance., PMID:25015375
Comparison of two ERCC1 antibodies as prognostic and predictive biomarkers for early non-small cell lung cancer., PMID:24982391
Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer., PMID:24817012
Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions., PMID:24799992
Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas., PMID:24692084
Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibody., PMID:24603753
Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal Cancer., PMID:24517959
ERCC1 expression correlated with EGFR and clinicopathological variables in patients with non-small cell lung cancer. An immunocytochemical study on fine-needle aspiration biopsies samples., PMID:24508180
Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells., PMID:24300914
Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy., PMID:24293473
Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers., PMID:24088734
ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial., PMID:24064970
A phase II clinical study of mFOLFOX6 plus bevacizumab as first-line therapy for Japanese advanced/recurrent colorectal cancer patients., PMID:23999770
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer., PMID:23514287
For research use only. Not for human or drug use.
